Hagop M Kantarjian (Hagop Kantarjian)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 312

Top Venues

American journal of hematology

Cancer

Leukemia

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology 99 (6) (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology 99 (6) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Branko Cuglievan, Hagop M Kantarjian, Jeffrey E Rubnitz, Todd M Cooper, C Michel Zwaan, Jessica A Pollard, Courtney D D DiNardo, Tapan Mahendra Kadia, Erin M Guest, Nicholas James Short, David C McCall, Naval G Daver, Cesar Nunez, Fadi G Haddad, Miriam B Garcia, Kapil N Bhalla, Abhishek Maiti, Samanta Catueno, Warren C Fiskus, Bing Z Carter, Amber Gibson, Michael Roth, Sajad Khazal, Priti Tewari, Hussein A Abbas, Wallace Bourgeois, Michael Andreeff, Neerav N Shukla, Danh D Truong, Jeremy Connors, Joseph A Ludwig, Janine Stutterheim, Elisabeth Salzer, Kristian L Juul-Dam, Koiji Sasaki, Kris M Mahadeo, Sarah K Tasian, Gautam Borthakur, Samantha Dickson, Nitin Jain, Elias J Jabbour, Soheil Meshinchi, Guillermo Garcia Manero, Farhad Ravandi, Eytan M Stein, E Anders Kolb, Ghayas C Issa
Menin inhibitors in pediatric acute leukemia: a comprehensive review and recommendations to accelerate progress in collaboration with adult leukemia and the international community. Leukemia (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Fady Gh Haddad, Koiji Sasaki, Jayastu Senapati, Lianchun Xiao, Grace S Hwang, Tareq Abuasab, Sangeetha Venugopal, Daniel Rivera, Alexandre Bazinet, Rodrick Babakhanlou, Kunhwa Kim, Faustine Ong, Sai Desikan, Naveen Pemmaraju, Sanam Loghavi, Gautam Borthakur, Courtney DiNardo, Hussein A Abbas, Nicholas James Short, Naval G Daver, Elias J Jabbour, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis. JCO oncology practice (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Ashley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, Koichi Takahashi, Ghayas C Issa, Hagop M Kantarjian, Courtney D D DiNardo, Caitlin R Rausch
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 130 (11) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Nicholas James Short, Fady Gh Haddad, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamana, Tapan Mahendra Kadia, Naval G Daver, Kelly Sharon Chien, Yesid Alvarado, Guillermo Garcia Manero, Ghayas C Issa, Rebecca Garris, Cedric Nasnas, Lewis Fady Nasr, Farhad Ravandi, Elias J Jabbour
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology (2024)
Sanam Loghavi, Qing Wei, Farhad Ravandi, Andres E Quesada, Mark J Routbort, Shimin Hu, Gokce A Toruner, Sa A Wang, Wei Wang, Roberto N Miranda, Shaoying Li, Jie Xu, Courtney D D DiNardo, Naval G Daver, Tapan Mahendra Kadia, Ghayas C Issa, Hagop M Kantarjian, L Jeffrey Medeiros, Guillin Tang
Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. American journal of hematology (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Alex Bataller, Alexandre Bazinet, Courtney D D DiNardo, Abhishek Maiti, Gautam Borthakur, Naval G Daver, Nicholas James Short, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Yilmaz, Guillermo Montalban Bravo, Koichi Takahashi, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclax. Blood advances 8 (4) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Fady Gh Haddad, Koiji Sasaki, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment-free remission in chronic myeloid leukemia. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology 99 (5) (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology 205 (1) (2024)
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, David McCue, Fadi G Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey L Jorgensen, Sa A Wang, Keyur Patel, Sanam Loghavi, Susan O'Brien, Farhad Ravandi
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia. Leukemia & lymphoma 65 (9) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer 130 (19) (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Wei-Ying Jen, Elias J Jabbour, Nicholas James Short, Ghayas C Issa, Fady Gh Haddad, Nitin Jain, Naveen Pemmaraju, Naval G Daver, Lucia Masarova, Gautam Borthakur, Kelly Sharon Chien, Rebecca Garris, Hagop M Kantarjian
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. American journal of hematology (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Wei-Ying Jen, Hagop M Kantarjian, Tapan Mahendra Kadia, Courtney D D DiNardo, Ghayas C Issa, Nicholas James Short, Musa Ylimaz, Gautam Borthakur, Farhad Ravandi, Naval G Daver
Combination therapy with novel agents for acute myeloid leukaemia: Insights into treatment of a heterogenous disease. British journal of haematology (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology 99 (7) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, Kelly Sharon Chien, Andres E Quesada, Emmanuel Almanza-Huante, Danielle Hammond, Koiji Sasaki, Courtney D D DiNardo, Tapan Mahendra Kadia, Naval G Daver, Gautam Borthakur, Ghayas C Issa, Nicholas James Short, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia Manero, Guillermo Montalban Bravo
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage. Cancer (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Tareq Abuasab, Gautam Borthakur, Rashmi Kanagal-Shamana, Lucia Masarova, Keyur Patel, Koichi Takahashi, Prithviraj Bose, John Villarreal, Sherry Pierce, Tapan Mahendra Kadia, Guillermo Garcia Manero, Nicholas James Short, Courtney D D DiNardo, Naval G Daver, Farhad Ravandi, Hagop M Kantarjian, Srdan Verstovsek, Musa Ylimaz
Exploring the landscape of somatic ASXL2 mutations in myeloid neoplasms: Frequency and clinical implications. American journal of hematology (2024)
Elias J Jabbour, Hagop M Kantarjian
Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. American journal of hematology (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Nicholas J Short, Hagop M Kantarjian, Elias Jabbour
Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens. Leukemia & lymphoma (2024)
Nicholas James Short, Elias J Jabbour, Lewis Fady Nasr, Nitin Jain, Fady Gh Haddad, Ghayas C Issa, Koiji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Y Konopleva, Farhad Ravandi, Hagop M Kantarjian
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology 99 (7) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer (2024)
Hagop M Kantarjian, Kebede H Begna, Elias J Jabbour, Shilpa Paul, Mary Alma Welch, Ayalew Tefferi
Optimal frontline therapy of chronic myeloid leukemia today, and related musings. American journal of hematology (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, David McCue, Fadi G Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey L Jorgensen, Sa A Wang, Keyur Patel, Sanam Loghavi, Susan O'Brien, Farhad Ravandi
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia. Leukemia & lymphoma (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, David McCue, Fadi G Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey L Jorgensen, Sa A Wang, Keyur Patel, Sanam Loghavi, Susan O'Brien, Farhad Ravandi
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia. Leukemia & lymphoma 65 (9) (2024)
Fady Gh Haddad, Koiji Sasaki, Lewis Fady Nasr, Nicholas James Short, Tapan Mahendra Kadia, Sara Dellasala, Jorge Cortes, Franck Emmanuel Nicolini, Ghayas C Issa, Elias J Jabbour, Hagop M Kantarjian
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase. Cancer (2024)
Alex Bataller, Courtney D D DiNardo, Alexandre Bazinet, Naval G Daver, Abhishek Maiti, Gautam Borthakur, Nicholas James Short, Koiji Sasaki, Elias J Jabbour, Ghayas C Issa, Naveen Pemmaraju, Musa Ylimaz, Guillermo Montalban Bravo, Sanam Loghavi, Guillermo Garcia Manero, Farhad Ravandi, Hagop M Kantarjian, Tapan Mahendra Kadia
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Hagop M Kantarjian, Gautam Borthakur, Naval G Daver, Courtney D D DiNardo, Ghayas C Issa, Elias J Jabbour, Tapan Mahendra Kadia, Koiji Sasaki, Nicholas James Short, Musa Ylimaz, Farhad Ravandi
Current status and research directions in acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Kelly Sharon Chien, Faustine Ong, Kunhwa Kim, Ziyi Li, Rashmi Kanagal-Shamana, Courtney D D DiNardo, Koichi Takahashi, Guillermo Montalban Bravo, Danielle Hammond, Koji Sasaki, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia-Manero
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms. Cancer medicine 13 (5) (2024)
Jayastu Senapati, Elias J Jabbour, Nicholas James Short, Nitin Jain, Fady Gh Haddad, Tharakeswara Bathala, Iuliia Kovalenko, Aram Bidikian, Farhad Ravandi, Issa Khouri, Tapan Mahendra Kadia, Rebecca Garris, Guillermo Montalban Bravo, Kelly Chien, Elizabeth Shpall, Partow Kebriaei, Hagop M Kantarjian
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin. Blood cancer journal 14 (1) (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma 65 (9) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 38 (3) (2024)
Georgina Gener-Ricos, Jan P Bewersdorf, Sanam Loghavi, Alex Bataller, Aaron D Goldberg, Koji Sasaki, Christopher Famulare, Koichi Takahashi, Ghayas C Issa, Gautam Borthakur, Tapan M Kadia, Nicholas J Short, Jayastu Senapati, Bing Z Carter, Keyur P Patel, Hagop M Kantarjian, Michael Andreeff, Eytan M Stein, Courtney D D DiNardo
TP53 Y220C mutations in patients with myeloid malignancies. Leukemia & lymphoma (2024)
Kelly Sharon Chien, Faustine Ong, Kunhwa Kim, Ziyi Li, Rashmi Kanagal-Shamana, Courtney D D DiNardo, Koichi Takahashi, Guillermo Montalban Bravo, Danielle Hammond, Koji Sasaki, Sherry A Pierce, Hagop M Kantarjian, Guillermo Garcia-Manero
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms. Cancer medicine 13 (5) (2024)
Elias J Jabbour, Jane F Apperley, Jorge E Cortes, Delphine Rea, Michael W Deininger, Elisabetta Abruzzese, Charles Chuah, Daniel J DeAngelo, Andreas Hochhaus, Jeffrey H Lipton, Michael J Mauro, Franck Nicolini, Javier Pinilla-Ibarz, Gianantonio Rosti, Philippe Rousselot, Neil P Shah, Moshe Talpaz, Alexander Vorog, Xiaowei Ren, Hagop M Kantarjian
Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Farhad Ravandi, Marion Subklewe, Roland Bruno Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D Baldus, Lars Fransecky, Timothy S Pardee, Hagop M Kantarjian, Priscilla K Yen, Lata Mukundan, Bharat Panwar, Marc R Yago, Suresh Agarwal, Sophia K Khaldoyanidi, Anthony Stein
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study. Leukemia & lymphoma 65 (9) (2024)
Elias J Jabbour, Fady Gh Haddad, Koiji Sasaki, Bing Z Carter, Yesid Alvarado, Cedric Nasnas, Lewis Fady Nasr, Lucia Masarova, Naval G Daver, Naveen Pemmaraju, Nicholas James Short, Jeffrey Skinner, Tapan Mahendra Kadia, Gautam Borthakur, Guillermo Garcia Manero, Farhad Ravandi, Ghayas C Issa, Michael Andreeff, Hagop M Kantarjian
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia. Cancer 130 (15) (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology 99 (4) (2024)
Elias J Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, Pilar Martínez-Sánchez, José J Rifón Roca, Ryan D Cassaday, Boris Böll, Anita Rijneveld, Maher Abdul-Hay, Françoise Huguet, Thomas Cluzeau, Mar Tormo Díaz, Vladan Vucinic, José González-Campos, Alessandro Rambaldi, Stefan Schwartz, Céline Berthon, Jesús María Hernández-Rivas, Paul R Gordon, Monika Brüggemann, Ali Hamidi, Yuqi Chen, Hansen L Wong, Bharat Panwar, Yuliya Katlinskaya, Ana Markovic, Hagop M Kantarjian
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia. American journal of hematology (2024)
Issa F Khouri, Kamal Alzahrani, Hagop M Kantarjian, Denái R Milton, Alison M Gulbis, Koiji Sasaki, Nitin Jain, Nicholas James Short, Tapan Mahendra Kadia, May Daher, Hind Rafei, Jin S Im, David Marin, Amanda L Olson, Uday R Popat, Muzaffar H Qazilbash, Jeremy Ramdial, Gabriela Rondon, Samer A Srour, Partow Kebriaei, Elizabeth Shpall, Richard Champlin, Elias J Jabbour
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. American journal of hematology (2024)
Ashley Dinh, J Michael Savoy, Dimitrios P Kontoyiannis, Koichi Takahashi, Ghayas C Issa, Hagop M Kantarjian, Courtney D D DiNardo, Caitlin R Rausch
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer (2024)
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, David McCue, Fadi G Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey L Jorgensen, Sa A Wang, Keyur Patel, Sanam Loghavi, Susan O'Brien, Farhad Ravandi
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia. Leukemia & lymphoma (2024)
Nicholas James Short, Naval G Daver, Courtney D D DiNardo, Tapan Mahendra Kadia, Lewis Fady Nasr, Walid Macaron, Musa Yilmaz, Gautam Borthakur, Guillermo Montalban-Bravo, Guillermo Garcia Manero, Ghayas C Issa, Kelly Sharon Chien, Elias J Jabbour, Cedric Nasnas, Xuelin Huang, Wei Qiao, Jairo Matthews, Christopher J Stojanik, Keyur Pravinchandra Patel, Regina Abramova, Jennifer Thankachan, Marina Y Konopleva, Hagop M Kantarjian, Farhad Ravandi
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Hagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, Marlise R Luskin, Matthias Stelljes, Anjali S Advani, Elias J Jabbour, Josep-María Ribera, David I Marks
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directions. Cancer (2024)
Jayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, Patrick K Reville, Nicholas James Short, Naval G Daver, Gautam Borthakur, Alex Bataller, Elias J Jabbour, Courtney D D DiNardo, Fady Gh Haddad, Koiji Sasaki, Uday R Popat, Betül Oran, Amin M Alousi, Sanam Loghavi, Elizabeth Shpall, Guillermo Garcia Manero, Farhad Ravandi, Tapan Mahendra Kadia
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation. Cancer 130 (19) (2024)
Hagop M Kantarjian, Helen T Chifotides, Fady Gh Haddad, Nicholas James Short, Sanam Loghavi, Elias J Jabbour
Ponatinib-review of historical development, current status, and future research. American journal of hematology 99 (8) (2024)
Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H Park, Nicolas Boissel, Hagop M Kantarjian
Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review. Leukemia & lymphoma (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Koiji Sasaki, Fady Gh Haddad, Nicholas James Short, Nitin Jain, Ghayas Issa, Elias J Jabbour, Hagop M Kantarjian
Outcome of Philadelphia chromosome-positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy-The Surveillance, Epidemiology, and End Results database, 2000-2019. Cancer (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology (2023)
Maria Siddiqui, Sergej Konoplev, Ghayas C Issa, Hagop M Kantarjian, Naval G Daver, Farhad Ravandi, Tapan Mahendra Kadia, Guillin Tang, Sa A Wang, Beenu Thakral, L Jeffrey Medeiros, Olga Pozdnyakova, Sherry Pierce, Guillermo Montalban-Bravo, Kelly Sharon Chien, Danielle Hammond, Koiji Sasaki, Guillermo Garcia-Manero, Robert P Hasserjian
Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. American journal of hematology 98 (4) (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)
Aram Bidikian, Elias J Jabbour, Ghayas C Issa, Nicholas James Short, Koiji Sasaki, Hagop M Kantarjian
Chronic Myeloid Leukemia Without Major Molecular Response After 2 Years of Treatment with Tyrosine Kinase Inhibitor. American journal of hematology (2023)
Hagop M Kantarjian, Mary Alma Welch, Koiji Sasaki
Early mortality after chemotherapy as a quality indicator-the leukemia perspective. Blood cancer journal 13 (1) (2023)
Elias J Jabbour, Koiji Sasaki, Fady Gh Haddad, Ghayas C Issa, Guillermo Garcia Manero, Tapan Mahendra Kadia, Nitin Jain, Musa Ylimaz, Courtney D D DiNardo, Keyur Patel, Rashmi Kanagal-Shamana, Richard Champlin, Issa F Khouri, Sara Dellasala, Sherry A Pierce, Hagop M Kantarjian
The Outcomes of Patients with Chronic Myeloid Leukemia Treated with Third-line BCR::ABL1 Tyrosine Kinase Inhibitors. American journal of hematology (2023)
Hagop M Kantarjian, Nicholas James Short, Nitin Jain, Koji Sasaki, Xuelin Huang, Fady Gh Haddad, Issa F Khouri, Courtney D D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia Manero, Partow Kebriaei, Rebecca Garris, Sanam Loghavi, Jeffrey Jorgensen, Monica Kwari, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Frontline combination of ponatinib and hyper-CVAD in Philadelphia chromosome-positive acute lymphoblastic leukemia: 80-months follow-up results. American journal of hematology 98 (3) (2023)
Hagop M Kantarjian, Aaron C Logan, Faraz Zaman, Nicola Gökbuget, Ralf C Bargou, Yi Zeng, Gerhard Zugmaier, Franco Locatelli
Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab. Therapeutic advances in hematology 14 (2023)
Tapan Mahendra Kadia, Farhad Ravandi, Matteo Molica, Alex Bataller, Gautam Borthakur, Naval G Daver, Elias J Jabbour, Courtney D D DiNardo, Naveen Pemmaraju, Nitin Jain, Alessandra Ferrajoli, Musa Ylimaz, Prithviraj Bose, Rebecca S Slack Tidwell, Kayleigh R Marx, Caitlin R Rausch, Rashmi Kanagal-Shamana, Sa A Wang, Rabiul Islam, Richard Champlin, Elizabeth Shpall, Marina Y Konopleva, Guillermo Garcia Manero, Hagop M Kantarjian
Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia. American journal of hematology (2023)
Jayastu Senapati, Koiji Sasaki, Ghayas C Issa, Jeffrey H Lipton, Jerald P Radich, Elias J Jabbour, Hagop M Kantarjian
Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood cancer journal 13 (1) (2023)

Hagop M Kantarjian.css-eqlu8i{font-size:small;padding-left:4px;} (Hagop Kantarjian)

Publication Activity (10 Years)

Top Topics

Top Venues

Hagop M Kantarjian (Hagop Kantarjian)